Localized aggressive non-Hodgkin's lymphoma of the nasal cavity: A survey by the Japan lymphoma radiation therapy group

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 5, 2001, Pages 1228-1233

  Shikama, Naoto ^a   Ikeda, Hiroshi ^b   Nakamura, Shigeo ^c   Oguchi, Masahiko ^d   Isobe, Kouichi ^d   Hirota, Saeko ^d   Hasegawa, Masatoshi ^d   Nakamura, Katsumasa ^d   Sasai, Keisuke ^d   Hayabuchi, Naofumi ^d  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Cancer Hospital East   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d Japan Lymphoma Radiation Therapy Group   (Japan)

Author keywords

Nasal cavity; Non Hodgkin's lymphoma; Prognostic factor; Radiation therapy

Indexed keywords

CELLS; CHEMOTHERAPY; PATIENT TREATMENT; RADIATION; RADIOTHERAPY;

CLINICAL DATA; NASAL CAVITY;

ONCOLOGY;

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; NOSE CAVITY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SURVIVAL RATE; T CELL LYMPHOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NOSE NEOPLASMS; SALVAGE THERAPY;

EID: 0035577651     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01800-4     Document Type: Article

References (19)

1. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: A survey of the Japan Lymphoma Radiation Therapy Group
2. Clinical stage IE primary lymphoma of the nasal cavity: Radiation therapy and chemotherapy
3. Primary Non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
4. Non-Hodgkin's lymphoma confined to the nasal cavity: Its relationship to the polymorphic reticulosis and results of radiation therapy
5. Malignant lymphomas of the nasal cavity and paranasal sinuses
6. Head and neck stages I and II extranodal non-Hodgkin's lymphomas: REAL classification and selection for treatment modality
7. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma
8. An ECOG randomized phase III trial of CHOP vs CHOP plus radiotherapy for intermediate grade early stage non-Hodgkin's lymphoma
9. A predictive model for aggressive non-Hodgkin's lymphoma
10. Nonparametric estimation from incomplete observations
11. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage
12. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
13. Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation
14. Lymphoma of the nasal cavity and paranasal sinuses: Improved outcome and altered prognostic factors with combined modality therapy
15. Angiocentric nasal T/natural killer cell lymphoma: A single centre study of prognostic factors in 108 patients
16. A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'
17. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract
18. Nasal-type T/NK lymphomas: A clinicopathologic study of 13 cases
19. CD56+ NK lymphomas: Clinicopathological features and prognosis